Schizophrenia is a chronic, severe, and highly heterogeneous psychiatric disorder. Current antipsychotic medications show limited effectiveness in treating negative symptoms and cognitive deficits. Accumulating evidence suggests that dysfunction of inhibitory γ-aminobutyric acid (GABA) neurons, leading to inhibitory circuit dysregulation, plays a pivotal role in the pathophysiology of the disorder. Recent advances in induced pluripotent stem cells (iPSCs) and brain organoid technologies have provided more accurate human-based models of schizophrenia, offering new avenues to investigate the complex neurodevelopmental mechanism of schizophrenia and to explore cell replacement therapies. Preclinical studies have demonstrated that transplantation of specific types of GABAergic interneuron precursors into the brain can selectively improve negative symptoms and cognitive deficits in animal models, highlighting considerable translational potential. However, the transition from bench to bedside still faces multiple technical and ethical challenges, enhancing cell differentiation efficiency, ensuring long-term safety of transplanted cells, achieving precise control and functional integration of neuronal subtypes, understanding circuit-specific contributions to different symptom domains, and establishing rigorous ethical and regulatory frameworks. In summary, inhibitory GABAergic interneuron-based cell therapy provides a novel theoretical and perspective foundation for improving negative and cognitive symptoms of schizophrenia. Despite significant challenges ahead, its prospects remain highly promising.

Schizophrenia is a chronic, severe, and highly heterogeneous psychiatric disorder. Current antipsychotic medications show limited effectiveness in treating negative symptoms and cognitive deficits. Accumulating evidence suggests that dysfunction of inhibitory γ-aminobutyric acid (GABA) neurons, leading to inhibitory circuit dysregulation, plays a pivotal role in the pathophysiology of the disorder. Recent advances in induced pluripotent stem cells (iPSCs) and brain organoid technologies have provided more accurate human-based models of schizophrenia, offering new avenues to investigate the complex neurodevelopmental mechanism of schizophrenia and to explore cell replacement therapies. Preclinical studies have demonstrated that transplantation of specific types of GABAergic interneuron precursors into the brain can selectively improve negative symptoms and cognitive deficits in animal models, highlighting considerable translational potential. However, the transition from bench to bedside still faces multiple technical and ethical challenges, enhancing cell differentiation efficiency, ensuring long-term safety of transplanted cells, achieving precise control and functional integration of neuronal subtypes, understanding circuit-specific contributions to different symptom domains, and establishing rigorous ethical and regulatory frameworks. In summary, inhibitory GABAergic interneuron-based cell therapy provides a novel theoretical and perspective foundation for improving negative and cognitive symptoms of schizophrenia. Despite significant challenges ahead, its prospects remain highly promising.

Objective:To investigate the efficacy and safety of accelerated epithelium-off corneal collagen cross-linking (CXL) in the treatment of corneal ectasia after keratorefractive surgery.Methods:An observational case series study was performed.Twelve patients (22 eyes) diagnosed with corneal ectasia after keratorefractive surgery in the First Affiliated Hospital of Army Medical University were enrolled from January 2016 to December 2018.All the patients received accelerated epithelium-off CXL and were followed up for 12 months.Before and 1 week, 1, 3, 6, and 12 months after the operation, the uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) converted to the logarithm of the minimum angle of resolution (LogMAR) unit were measured.The sphericity, cylindricity, and spherical equivalent were examined by Topcon auto refractor.The maximum keratometry (Kmax) of the front surface, mean keratometry (Km) of the front surface, Km of the back surface, symmetry index of front surface (SIf), symmetry index of back surface (SIb), thinnest corneal thickness (TCT), total aberrations, total high-order aberrations, coma aberration, trefoil aberration and spherical aberration were detected by the Sirius analyzer.The depth of corneal demarcation lines was determined by optical coherence tomography.The intraocular pressure was measured by the non-contact tonometry.The corneal endothelial cell density was assayed by the endothelial cell densitometry.The inflammatory reaction and haze were observed with a slit lamp at different time points after surgery.This study adhered to the Declaration of Helsinki.The study protocol was approved by the First Affiliated Hospital of Army Medical University (No.KY2020063). Written informed consent was obtained from each patient before entering the cohort.Results:Among the 22 eyes of 12 cases, 3 eyes of 2 cases (13.64%) underwent small incision lenticule extraction, and 19 eyes of 10 cases (86.36%) underwent excimer laser in situ keratomileusis.The UCVA (LogMAR), BCVA (LogMAR), cylindricity and spherical equivalent before the operation were 0.61±0.42, 0.24±0.23, (-2.83±2.39)D, (-3.60±2.66)D, which were significantly worse than 0.45±0.31, 0.12±0.15, (-2.11±1.67)D, (-3.12±2.31)D at 12 months after the operation ( t=4.054, 4.956, -3.728, -2.742; all at P<0.05). The front surface Kmax, front surface Km and SIf at 12 months after the operation were (48.37±5.80), (41.49±3.04), (5.36±4.07)D, which were significantly lower than (49.61±5.97), (41.66±2.97), (5.85±4.18)D before the operation ( t=5.949, 2.278, 2.719; all at P<0.05). There was no significant difference in sphericity, Km of the back surface, SIb, TCT, total aberrations, total high-order aberrations, coma aberration, trefoil aberration, spherical aberration, intraocular pressure and endothelial cell density between before and 12 months after the operation (all at P>0.05). Grade 0.5-2 haze occurred in 8 eyes of 4 patients one month postoperatively.After administration of prednisolone acetate eye drops, haze decreased or disappeared 3 months postoperatively, with UCVA and BCVA unchanged.A corneal demarcation line with a depth of (285.40±51.61)μm was found in 11 eyes of 6 cases at 1 month after operation. Conclusions:Accelerated epithelium-off CXL can significantly improve visual acuity, reduce corneal astigmatism and corneal curvature, as well as effectively prevent the progress of corneal ectasia.

OBJECTIVE: To investigate imaging and audiology features of temporal bone and analyze the classification and prevalence of inner ear abnormalities in children with sensorineural hearing loss. METHOD: Children who were diagnosed with sensorineural hearing loss were examined by high resolution CT and the inner ear fluid of MRI. And each chart was retrospectively reviewed to determine the imaging and audiology features. RESULT: There were 125 patients(232 ears) found with inner ear malformation in 590 children with SNHL. About 21.71% of the inner ear malformation occurred in severe and profound hearing loss ears, and 12.85% occurred in r moderate hearing loss ears. The inner ear malformation rate in normal hearing ears were 13.59%. CONCLUSION CT and MRI examinations of temporal bone are important diagnostic tools to indentify inner ear malformations. Inner ear malformations are almost bilateral and hearing loss are profoud. Cochleo-vestibular malformations and large vestibular aqueduct are the 2 most frequent deformities. Among the children with SNHL, deformity rate in the severe and profound hearing loss ears is higher than that in moderate hearing loss ear. Inner ear malformations can exist in people with normal hearing.
Audiology ; Child ; Ear, Inner ; abnormalities ; Hearing Loss, Sensorineural ; congenital ; pathology ; Humans ; Magnetic Resonance Imaging ; Prevalence ; Retrospective Studies ; Temporal Bone ; Tomography, X-Ray Computed ; Vestibular Aqueduct ; abnormalities